142 related articles for article (PubMed ID: 32340855)
1. Seizures during treatment of childhood acute lymphoblastic leukemia: A population-based cohort study.
Anastasopoulou S; Heyman M; Eriksson MA; Niinimäki R; Taskinen M; Mikkel S; Vaitkeviciene GE; Johannsdottir IM; Myrberg IH; Jonsson OG; Als-Nielsen B; Schmiegelow K; Banerjee J; Ranta S; Harila-Saari A
Eur J Paediatr Neurol; 2020 Jul; 27():72-77. PubMed ID: 32340855
[TBL] [Abstract][Full Text] [Related]
2. Posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia: Clinical characteristics, risk factors, course, and outcome of disease.
Anastasopoulou S; Eriksson MA; Heyman M; Wang C; Niinimäki R; Mikkel S; Vaitkevičienė GE; Johannsdottir IM; Myrberg IH; Jonsson OG; Als-Nielsen B; Schmiegelow K; Banerjee J; Harila-Saari A; Ranta S
Pediatr Blood Cancer; 2019 May; 66(5):e27594. PubMed ID: 30592147
[TBL] [Abstract][Full Text] [Related]
3. Posterior Reversible Encephalopathy Syndrome: Risk Factors and Impact on the Outcome in Children With Acute Lymphoblastic Leukemia Treated With Nordic Protocols.
Banerjee JS; Heyman M; Palomäki M; Lähteenmäki P; Arola M; Riikonen PV; Möttönen MI; Lönnqvist T; Taskinen MH; Harila-Saari AH
J Pediatr Hematol Oncol; 2018 Jan; 40(1):e13-e18. PubMed ID: 29200159
[TBL] [Abstract][Full Text] [Related]
4. Acute central nervous system toxicity during treatment of pediatric acute lymphoblastic leukemia: phenotypes, risk factors and genotypes.
Anastasopoulou S; Nielsen RL; Als-Nielsen B; Banerjee J; Eriksson MA; Helenius M; Heyman MM; Johannsdottir IM; Jonsson OG; MacGregor S; Mateos MK; Mayoh C; Mikkel S; Myrberg IH; Niinimäki R; Schmiegelow K; Taskinen M; Vaitkeviciene G; Warnqvist A; Wolthers B; Harila-Saari A; Ranta S
Haematologica; 2022 Oct; 107(10):2318-2328. PubMed ID: 35354251
[TBL] [Abstract][Full Text] [Related]
5. Posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia during remission induction chemotherapy: a single-center retrospective study.
Lin W; Xie J; Zhang J; Cheng H; Cui H; Zhang Y; Wu Y; Yu J; Qi P; Fan J; Gao H; Wang F; Zhang R; Zheng H
Minerva Pediatr (Torino); 2023 Dec; 75(6):808-816. PubMed ID: 31729207
[TBL] [Abstract][Full Text] [Related]
6. Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years.
Rank CU; Toft N; Tuckuviene R; Grell K; Nielsen OJ; Frandsen TL; Marquart HVH; Albertsen BK; Tedgård U; Hallböök H; Ruud E; Jarvis KB; Quist-Paulsen P; Huttunen P; Wartiovaara-Kautto U; Jónsson ÓG; Trakymiene SS; Griškevičius L; Saks K; Punab M; Schmiegelow K
Blood; 2018 May; 131(22):2475-2484. PubMed ID: 29661787
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous occurrence of posterior reversible leukoencephalopathy syndrome in two cases of childhood acute lymphoblastic leukemia induction chemotherapy.
Gupta A; Swaroop C; Rastogi R; Garg R; Bakhshi S
Pediatr Hematol Oncol; 2008 Jun; 25(4):351-8. PubMed ID: 18484481
[TBL] [Abstract][Full Text] [Related]
8. Cerebral sinus venous thromboses in children with acute lymphoblastic leukaemia - a multicentre study from the Nordic Society of Paediatric Haematology and Oncology.
Ranta S; Tuckuviene R; Mäkipernaa A; Albertsen BK; Frisk T; Tedgård U; Jónsson ÓG; Pruunsild K; Gretenkort Andersson N; Winther Gunnes M; Saulyte Trakymiene S; Frandsen T; Heyman M; Ruud E; Helgestad J
Br J Haematol; 2015 Feb; 168(4):547-52. PubMed ID: 25288392
[TBL] [Abstract][Full Text] [Related]
9. Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia.
Toft N; Birgens H; Abrahamsson J; Griškevičius L; Hallböök H; Heyman M; Klausen TW; Jónsson ÓG; Palk K; Pruunsild K; Quist-Paulsen P; Vaitkeviciene G; Vettenranta K; Asberg A; Helt LR; Frandsen T; Schmiegelow K
Eur J Haematol; 2016 Feb; 96(2):160-9. PubMed ID: 25867866
[TBL] [Abstract][Full Text] [Related]
10. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial.
Nielsen SN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Hjalgrim LL; Schmiegelow K
Lancet Oncol; 2017 Apr; 18(4):515-524. PubMed ID: 28258828
[TBL] [Abstract][Full Text] [Related]
11. The spectrum of acute central nervous system symptoms during the treatment of childhood acute lymphoblastic leukaemia.
Banerjee J; Niinimäki R; Lähteenmäki P; Hed Myrberg I; Arola M; Riikonen P; Lönnqvist T; Palomäki M; Ranta S; Harila-Saari A; Taskinen M
Pediatr Blood Cancer; 2020 Feb; 67(2):e27999. PubMed ID: 31674724
[TBL] [Abstract][Full Text] [Related]
12. Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia.
Mogensen SS; Harila-Saari A; Mäkitie O; Myrberg IH; Niinimäki R; Vestli A; Hafsteinsdottir S; Griškevicius L; Saks K; Hallböök H; Retpen J; Helt LR; Toft N; Schmiegelow K; Frandsen TL;
Pediatr Blood Cancer; 2018 Oct; 65(10):e27300. PubMed ID: 29943905
[TBL] [Abstract][Full Text] [Related]
13. PEG-asparaginase allergy in children with acute lymphoblastic leukemia in the NOPHO ALL2008 protocol.
Henriksen LT; Harila-Saari A; Ruud E; Abrahamsson J; Pruunsild K; Vaitkeviciene G; Jónsson ÓG; Schmiegelow K; Heyman M; Schrøder H; Albertsen BK;
Pediatr Blood Cancer; 2015 Mar; 62(3):427-33. PubMed ID: 25418987
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of thromboembolism in 1038 children with acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology (NOPHO) study.
Tuckuviene R; Ranta S; Albertsen BK; Andersson NG; Bendtsen MD; Frisk T; Gunnes MW; Helgestad J; Heyman MM; Jonsson OG; Mäkipernaa A; Pruunsild K; Tedgård U; Trakymiene SS; Ruud E
J Thromb Haemost; 2016 Mar; 14(3):485-94. PubMed ID: 26707629
[TBL] [Abstract][Full Text] [Related]
15. Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites.
Toksvang LN; De Pietri S; Nielsen SN; Nersting J; Albertsen BK; Wehner PS; Rosthøj S; Lähteenmäki PM; Nilsson D; Nystad TA; Grell K; Frandsen TL; Schmiegelow K
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28423235
[TBL] [Abstract][Full Text] [Related]
16. Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemia.
Toft N; Birgens H; Abrahamsson J; Griškevičius L; Hallböök H; Heyman M; Klausen TW; Jónsson ÓG; Palk K; Pruunsild K; Quist-Paulsen P; Vaitkeviciene G; Vettenranta K; Åsberg A; Frandsen TL; Marquart HV; Madsen HO; Norén-Nyström U; Schmiegelow K
Leukemia; 2018 Mar; 32(3):606-615. PubMed ID: 28819280
[TBL] [Abstract][Full Text] [Related]
17. Predisposing factors of posterior reversible encephalopathy syndrome in acute childhood leukemia.
Kim SJ; Im SA; Lee JW; Chung NG; Cho B; Kim HK; Lee IG
Pediatr Neurol; 2012 Dec; 47(6):436-42. PubMed ID: 23127265
[TBL] [Abstract][Full Text] [Related]
18. Neurocognitive outcomes among children who experienced seizures during treatment for acute lymphoblastic leukemia.
Nassar SL; Conklin HM; Zhou Y; Ashford JM; Reddick WE; Glass JO; Laningham FH; Jeha S; Cheng C; Pui CH
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28130818
[TBL] [Abstract][Full Text] [Related]
19. Prognosis and treatment of seizures in children with acute lymphoblastic leukemia.
Maytal J; Grossman R; Yusuf FH; Shende AC; Karayalycin G; Lanzkowsky P; Schaul N; Eviatar L
Epilepsia; 1995 Aug; 36(8):831-6. PubMed ID: 7635103
[TBL] [Abstract][Full Text] [Related]
20. Asparaginase-associated pancreatitis in children with acute lymphoblastic leukaemia in the NOPHO ALL2008 protocol.
Raja RA; Schmiegelow K; Albertsen BK; Prunsild K; Zeller B; Vaitkeviciene G; Abrahamsson J; Heyman M; Taskinen M; Harila-Saari A; Kanerva J; Frandsen TL;
Br J Haematol; 2014 Apr; 165(1):126-33. PubMed ID: 24428625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
